MN 566 FINAL EXAM 2026/2027 | Advanced NP Practice
Questions & Verified Answers | Grade A | Pass Guaranteed -
A+ Graded
SECTION 1: ADVANCED HEALTH ASSESSMENT & DIAGNOSTIC
REASONING (Questions 1-35)
Q1: A 58-year-old African American male presents for a routine physical examination.
He has a history of hypertension controlled with lisinopril 10 mg daily. His blood
pressure today is 142/88 mmHg in the right arm after sitting quietly for 5 minutes. On
repeat measurement 2 minutes later, it is 138/86 mmHg. He denies chest pain, dyspnea,
or dizziness. His BMI is 31.2 kg/m². Which of the following is the most appropriate next
step in management according to current ACC/AHA hypertension guidelines?
A. Increase lisinopril to 20 mg daily because the initial reading exceeds 140/90 mmHg
B. Recheck blood pressure in both arms using proper technique after 5 minutes of rest;
average the readings
C. Add hydrochlorothiazide 12.5 mg daily to achieve dual therapy immediately
D. Order ambulatory blood pressure monitoring because the readings are inconsistent
Correct Answer: B
Rationale: According to the 2017 ACC/AHA Hypertension Guidelines (and reaffirmed in
2026 clinical practice updates), proper blood pressure measurement technique requires
taking at least two readings 1-2 minutes apart and averaging them. The initial reading of
142/88 mmHg and repeat of 138/86 mmHg should be averaged to approximately
140/87 mmHg, which falls into Stage 1 hypertension. However, before escalating
therapy, the clinician must ensure proper technique: patient seated with back supported,
,feet flat, arm at heart level, appropriate cuff size, and no conversation during
measurement. Option A is incorrect because medication adjustments should not be
based on a single elevated reading without confirming technique. Option C is incorrect
because dual therapy is not indicated without confirmed uncontrolled hypertension and
proper lifestyle counseling. Option D is incorrect because ambulatory monitoring is
reserved for suspected white coat hypertension or resistant hypertension, not routine
confirmation of office readings.
Q2: A 42-year-old female presents with a 3-week history of progressive fatigue, weight
loss of 8 pounds, and palpitations. Physical examination reveals a resting tremor, fine
hair, and warm, moist skin. Laboratory studies show TSH 0.01 mIU/L (low), free T4 2.8
ng/dL (elevated), and T3 220 ng/dL (elevated). She has no known thyroid disease.
Which diagnostic study is most appropriate to determine the etiology of her
hyperthyroidism?
A. Thyroid ultrasound with Doppler to assess vascularity and nodules
B. Radioactive iodine uptake (RAIU) and scan
C. Thyroid peroxidase (TPO) antibody testing
D. Fine-needle aspiration biopsy of the thyroid gland
Correct Answer: B
Rationale: Radioactive iodine uptake (RAIU) and scan is the gold standard for
differentiating the etiology of hyperthyroidism. Diffuse increased uptake indicates
Graves' disease (autoimmune), while focal increased uptake suggests a toxic adenoma
or toxic multinodular goiter. Decreased uptake suggests thyroiditis (subacute, silent, or
postpartum) or exogenous thyroid hormone ingestion. Option A is useful for evaluating
nodules and gland size but does not differentiate functional status or etiology of
hyperthyroidism. Option C (TPO antibodies) is primarily used for diagnosing
Hashimoto's thyroiditis and has limited utility in hyperthyroidism workup; TSH receptor
,antibodies (TRAb) would be more appropriate for Graves' disease but RAIU remains the
definitive test. Option D is indicated for evaluating suspicious thyroid nodules (per ATA
2015 guidelines, updated 2026) but is contraindicated in hyperthyroidism evaluation
without a discrete nodule requiring cytologic assessment.
Q3: A 67-year-old male with a 40-pack-year smoking history presents with a new cough,
hemoptysis, and 15-pound weight loss over 2 months. Chest X-ray reveals a 3.5 cm
spiculated mass in the right upper lobe. Which of the following is the most appropriate
next step in the diagnostic workup?
A. Positron emission tomography (PET) scan to evaluate for metastatic disease
B. CT-guided transthoracic needle biopsy of the mass
C. Bronchoscopy with biopsy and endobronchial ultrasound (EBUS) for mediastinal
staging
D. Surgical resection with lobectomy given the high suspicion for malignancy
Correct Answer: C
Rationale: According to NCCN Guidelines for Non-Small Cell Lung Cancer (Version
2.2026) and ACCP guidelines, the initial diagnostic and staging approach for suspected
lung cancer should begin with the least invasive method that offers both tissue
diagnosis and staging. Bronchoscopy with biopsy allows direct visualization and tissue
acquisition from the primary lesion, while EBUS enables mediastinal lymph node
sampling (N2/N3 disease) which is critical for staging and determines resectability.
Option A (PET scan) is important for staging but should not precede tissue diagnosis.
Option B (CT-guided biopsy) is appropriate for peripheral lesions but does not provide
mediastinal staging and carries higher pneumothorax risk. Option D (surgical resection)
is inappropriate without histologic confirmation of malignancy and complete staging;
surgical intervention without confirmed cancer diagnosis violates oncologic standards
of care.
, Q4: A 55-year-old female with type 2 diabetes mellitus presents for a routine follow-up.
Her HbA1c is 8.2% on metformin 1000 mg BID. She has no history of cardiovascular
disease, eGFR is 72 mL/min/1.73m², and liver function tests are normal. Her BMI is 33
kg/m². According to the ADA 2026 Standards of Care, which medication should be
added to her regimen?
A. Glipizide 5 mg daily to provide additional glycemic control at lowest cost
B. Empagliflozin 10 mg daily for cardiovascular risk reduction and glycemic efficacy
C. Pioglitazone 30 mg daily to improve insulin sensitivity without hypoglycemia risk
D. NPH insulin 10 units at bedtime to achieve rapid glycemic control
Correct Answer: B
Rationale: The ADA 2026 Standards of Care recommend that for patients with type 2
diabetes and HbA1c above target (generally <7% individualized) on metformin, the
addition of an agent with proven cardiovascular benefit is preferred, particularly for
patients with overweight/obesity or cardiovascular risk factors. Empagliflozin (SGLT2
inhibitor) has demonstrated cardiovascular risk reduction in the EMPA-REG OUTCOME
trial and provides weight loss, blood pressure reduction, and renal protection. Option A
(glipizide/sulfonylurea) is not preferred due to hypoglycemia risk, weight gain, and lack
of cardiovascular benefit. Option C (pioglitazone) causes weight gain, fluid retention,
and has cardiovascular concerns including heart failure exacerbation. Option D (insulin)
is not indicated as second-line therapy when oral agents are appropriate; insulin is
reserved for HbA1c >10%, symptomatic hyperglycemia, or failure of multiple oral
agents.
Q5: A 38-year-old male presents with acute onset of severe chest pain radiating to the
back, described as "tearing." He is diaphoretic and hypertensive with BP 190/110
mmHg. Chest X-ray shows mediastinal widening. ECG shows nonspecific ST-T wave
changes. Which of the following is the most appropriate immediate diagnostic test?
Questions & Verified Answers | Grade A | Pass Guaranteed -
A+ Graded
SECTION 1: ADVANCED HEALTH ASSESSMENT & DIAGNOSTIC
REASONING (Questions 1-35)
Q1: A 58-year-old African American male presents for a routine physical examination.
He has a history of hypertension controlled with lisinopril 10 mg daily. His blood
pressure today is 142/88 mmHg in the right arm after sitting quietly for 5 minutes. On
repeat measurement 2 minutes later, it is 138/86 mmHg. He denies chest pain, dyspnea,
or dizziness. His BMI is 31.2 kg/m². Which of the following is the most appropriate next
step in management according to current ACC/AHA hypertension guidelines?
A. Increase lisinopril to 20 mg daily because the initial reading exceeds 140/90 mmHg
B. Recheck blood pressure in both arms using proper technique after 5 minutes of rest;
average the readings
C. Add hydrochlorothiazide 12.5 mg daily to achieve dual therapy immediately
D. Order ambulatory blood pressure monitoring because the readings are inconsistent
Correct Answer: B
Rationale: According to the 2017 ACC/AHA Hypertension Guidelines (and reaffirmed in
2026 clinical practice updates), proper blood pressure measurement technique requires
taking at least two readings 1-2 minutes apart and averaging them. The initial reading of
142/88 mmHg and repeat of 138/86 mmHg should be averaged to approximately
140/87 mmHg, which falls into Stage 1 hypertension. However, before escalating
therapy, the clinician must ensure proper technique: patient seated with back supported,
,feet flat, arm at heart level, appropriate cuff size, and no conversation during
measurement. Option A is incorrect because medication adjustments should not be
based on a single elevated reading without confirming technique. Option C is incorrect
because dual therapy is not indicated without confirmed uncontrolled hypertension and
proper lifestyle counseling. Option D is incorrect because ambulatory monitoring is
reserved for suspected white coat hypertension or resistant hypertension, not routine
confirmation of office readings.
Q2: A 42-year-old female presents with a 3-week history of progressive fatigue, weight
loss of 8 pounds, and palpitations. Physical examination reveals a resting tremor, fine
hair, and warm, moist skin. Laboratory studies show TSH 0.01 mIU/L (low), free T4 2.8
ng/dL (elevated), and T3 220 ng/dL (elevated). She has no known thyroid disease.
Which diagnostic study is most appropriate to determine the etiology of her
hyperthyroidism?
A. Thyroid ultrasound with Doppler to assess vascularity and nodules
B. Radioactive iodine uptake (RAIU) and scan
C. Thyroid peroxidase (TPO) antibody testing
D. Fine-needle aspiration biopsy of the thyroid gland
Correct Answer: B
Rationale: Radioactive iodine uptake (RAIU) and scan is the gold standard for
differentiating the etiology of hyperthyroidism. Diffuse increased uptake indicates
Graves' disease (autoimmune), while focal increased uptake suggests a toxic adenoma
or toxic multinodular goiter. Decreased uptake suggests thyroiditis (subacute, silent, or
postpartum) or exogenous thyroid hormone ingestion. Option A is useful for evaluating
nodules and gland size but does not differentiate functional status or etiology of
hyperthyroidism. Option C (TPO antibodies) is primarily used for diagnosing
Hashimoto's thyroiditis and has limited utility in hyperthyroidism workup; TSH receptor
,antibodies (TRAb) would be more appropriate for Graves' disease but RAIU remains the
definitive test. Option D is indicated for evaluating suspicious thyroid nodules (per ATA
2015 guidelines, updated 2026) but is contraindicated in hyperthyroidism evaluation
without a discrete nodule requiring cytologic assessment.
Q3: A 67-year-old male with a 40-pack-year smoking history presents with a new cough,
hemoptysis, and 15-pound weight loss over 2 months. Chest X-ray reveals a 3.5 cm
spiculated mass in the right upper lobe. Which of the following is the most appropriate
next step in the diagnostic workup?
A. Positron emission tomography (PET) scan to evaluate for metastatic disease
B. CT-guided transthoracic needle biopsy of the mass
C. Bronchoscopy with biopsy and endobronchial ultrasound (EBUS) for mediastinal
staging
D. Surgical resection with lobectomy given the high suspicion for malignancy
Correct Answer: C
Rationale: According to NCCN Guidelines for Non-Small Cell Lung Cancer (Version
2.2026) and ACCP guidelines, the initial diagnostic and staging approach for suspected
lung cancer should begin with the least invasive method that offers both tissue
diagnosis and staging. Bronchoscopy with biopsy allows direct visualization and tissue
acquisition from the primary lesion, while EBUS enables mediastinal lymph node
sampling (N2/N3 disease) which is critical for staging and determines resectability.
Option A (PET scan) is important for staging but should not precede tissue diagnosis.
Option B (CT-guided biopsy) is appropriate for peripheral lesions but does not provide
mediastinal staging and carries higher pneumothorax risk. Option D (surgical resection)
is inappropriate without histologic confirmation of malignancy and complete staging;
surgical intervention without confirmed cancer diagnosis violates oncologic standards
of care.
, Q4: A 55-year-old female with type 2 diabetes mellitus presents for a routine follow-up.
Her HbA1c is 8.2% on metformin 1000 mg BID. She has no history of cardiovascular
disease, eGFR is 72 mL/min/1.73m², and liver function tests are normal. Her BMI is 33
kg/m². According to the ADA 2026 Standards of Care, which medication should be
added to her regimen?
A. Glipizide 5 mg daily to provide additional glycemic control at lowest cost
B. Empagliflozin 10 mg daily for cardiovascular risk reduction and glycemic efficacy
C. Pioglitazone 30 mg daily to improve insulin sensitivity without hypoglycemia risk
D. NPH insulin 10 units at bedtime to achieve rapid glycemic control
Correct Answer: B
Rationale: The ADA 2026 Standards of Care recommend that for patients with type 2
diabetes and HbA1c above target (generally <7% individualized) on metformin, the
addition of an agent with proven cardiovascular benefit is preferred, particularly for
patients with overweight/obesity or cardiovascular risk factors. Empagliflozin (SGLT2
inhibitor) has demonstrated cardiovascular risk reduction in the EMPA-REG OUTCOME
trial and provides weight loss, blood pressure reduction, and renal protection. Option A
(glipizide/sulfonylurea) is not preferred due to hypoglycemia risk, weight gain, and lack
of cardiovascular benefit. Option C (pioglitazone) causes weight gain, fluid retention,
and has cardiovascular concerns including heart failure exacerbation. Option D (insulin)
is not indicated as second-line therapy when oral agents are appropriate; insulin is
reserved for HbA1c >10%, symptomatic hyperglycemia, or failure of multiple oral
agents.
Q5: A 38-year-old male presents with acute onset of severe chest pain radiating to the
back, described as "tearing." He is diaphoretic and hypertensive with BP 190/110
mmHg. Chest X-ray shows mediastinal widening. ECG shows nonspecific ST-T wave
changes. Which of the following is the most appropriate immediate diagnostic test?
